98%
921
2 minutes
20
This cross-sectional observational study aimed to identify the predictors of sleep bruxism (SB) in patients with temporomandibular disorder (TMD) and to comprehensively investigate its association with clinical, sleep-related, psychological, and hematological factors. Seventy-nine patients with TMD (69 females and 10 males; mean age 45.46 ± 14.46 years) were divided into two groups based on the presence or absence of SB: TMD_nonbruxer and TMD_bruxer. Descriptive statistics, correlation analyses, and multivariate stepwise logistic regression were conducted; p < 0.05 was considered statistically significant. In Cramer's V, SB was correlated with several clinical and sleep-related factors, including TMJ noise (r = 0.52), TMD pain (r = 0.48), craniomandibular index (r = 0.32), limited mouth opening (r = 0.29), tinnitus (r = 0.29), an increase in the Pittsburgh sleep quality index (PSQI) global score (r = 0.24), and poor sleep quality, defined as a PSQI global score ≥ 5 (r = 0.19) (all p < 0.05). SB was also associated with psychological distress. Regarding hematological factors, elevated levels of cortisol (r = 0.30), adrenocorticotropic hormone (ACTH) (r = 0.34), and cortisol/ACTH ratio (r = 0.35) were also associated with SB (all p < 0.05). The factors associated with an increased likelihood of SB ranked in terms of the odds ratio (OR) were: craniomandibular index (OR = 18.400, p = 0.006), poor sleep quality with a PSQI global score ≥ 5 (OR = 11.425, p = 0.027), depression (OR = 1.189, p = 0.014), cortisol/ACTH ratio (OR = 1.151, p = 0.007), anxiety (OR = 1.081, p = 0.040), and adrenocorticotropic hormone (OR = 1.073, p = 0.019). Notably, an increase in age was associated with a decreased likelihood of SB (OR = 0.905, p = 0.006), with a cut-off value of 50 years (AUC = 0.259, 95% CI: 0.149-0.368, p = 0.024), indicating a significant decrease in bruxism occurrence in individuals aged ≥ 50 years. Further analysis revealed complex interconnections between SB and its predictors. In conclusion, SB in TMD patients was associated with age < 50 years, various clinical factors, such as TMD pain and TMJ noise, poor sleep quality, psychological deterioration, and elevated cortisol and ACTH levels.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126533 | PMC |
http://dx.doi.org/10.1038/s41598-025-03339-3 | DOI Listing |
Asia Pac J Oncol Nurs
December 2025
Nursing Department, The Third Xiangya Hospital, Central South University, Changsha, China.
Objective: To identify latent subgroups of financial toxicity among patients with hematologic malignancies, examine associated sociodemographic and clinical predictors, and explore the relationship between financial toxicity and anxiety-depression symptoms.
Methods: A cross-sectional study was conducted among 486 patients with hematologic malignancies recruited through convenience sampling from provincial-level hospitals in Hunan Province, China. Participants completed the General Information Questionnaire, the Patient-Reported Outcome Financial Toxicity (PRO-FT) Scale, the Patient Health Questionnaire-4 (PHQ-4), and the Perceived Social Support Scale (PSSS).
PLoS One
September 2025
Department of Pediatric Hemato-Oncology, La Paz University Hospital, Madrid, Spain.
This randomized controlled trial aims to evaluate the efficacy of a cognitive training program using video games in improving neuropsychological, neurological, immunological, and inflammatory parameters in childhood cancer survivors. This study will recruit 56 patients aged 8-17 years who have completed cancer treatment 1-8 years prior to enrollment. Participants will be randomized to either the video game intervention or waiting group.
View Article and Find Full Text PDFMedicina (Kaunas)
July 2025
Department of Internal Medicine, Elazığ Fethi Sekin City Hospital, Elazığ 23300, Turkey.
Despite being highly prevalent among women of reproductive age, the psychological dimensions of iron deficiency anemia (IDA) often go unrecognized. While the hematological consequences of IDA are well established, emerging evidence suggests that it may also adversely affect emotional processing, mental health, and overall quality of life. This study aimed to systematically assess levels of alexithymia, anxiety, depressive symptoms, and quality of life in women diagnosed with IDA compared to age-matched healthy controls.
View Article and Find Full Text PDFBiomedicines
August 2025
Primary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
: Subcutaneous immunoglobulin (SCIg) is a well-established alternative to intravenous immunoglobulin (IVIg) in patients with primary (PID) and secondary immunodeficiency (SID), with demonstrated benefits in safety and quality of life. However, its implementation remains limited in parts of Southern Europe, partly due to frequent local adverse reactions (LARs), which, despite being mild, can affect adherence and clinician confidence. This study aimed to identify clinical, anatomical, psychosocial, and geographical factors associated with LARs and to develop an exploratory model for individualized risk estimation.
View Article and Find Full Text PDFPediatr Blood Cancer
October 2025
Section of Pediatric Hematology and Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Health disparities in pediatric, adolescent, and young adult (AYA) oncology remain a significant challenge, with socioeconomic status, geographic location, race, and ethnicity contributing to unequal access to care and poorer outcomes. Emerging technologies, including artificial intelligence (AI) and immersive tools such as virtual and augmented reality (VR/AR), offer transformative solutions to address these inequities. AI has demonstrated potential in enhancing diagnostic accuracy, tailoring treatment plans, and providing personalized patient navigation to guide families through complex care pathways.
View Article and Find Full Text PDF